Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
63.93
+0.29 (+0.46%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stocks Edge Up As Producer Inflation Supports Rate Cut Bets, Small Caps, Miners Rally: What's Driving Markets Thursday?
September 12, 2024
At midday on Thursday, Wall Street was showing slight gains, with small caps leading the charge. The Russell 2000 index surged 1.2%, outperforming large-cap indices in a notable rebound.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Moderna Outlines Post-Covid Roadmap, Cuts Research Budget, Forecasts 2025 Sales Below Expectations
September 12, 2024
Moderna highlights its mRNA pipeline and financial strategy at R&D Day and aims for 10 product approvals by 2027, expects to reduce R&D spending by $1.1 billion, and projects profitability for its...
Via
Benzinga
Nasdaq, S&P 500 Set For Modest Gains As Investors Eye August Inflation Data And ECB Rate Decision
September 12, 2024
U.S. stocks could open Thursday’s session modestly higher after the remarkable recovery they staged in the previous session. The spotlight is on the producer price inflation report for August as...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Check Out What Whales Are Doing With MRNA
September 10, 2024
Via
Benzinga
A Closer Look at Moderna's Options Market Dynamics
September 09, 2024
Via
Benzinga
Smart Money Is Betting Big In MRNA Options
September 04, 2024
Via
Benzinga
Wellness In Your Personal Life Unleashes Productivity At Work
August 30, 2024
Our world is obsessed with individual productivity.
Via
Investor's Business Daily
Moderna To Slash $1.1 Billion From R&D Spending In Major Commercial Push
September 12, 2024
The company says it's investment in R&D has paid off. Now, it needs to move its focus to launching new products.
Via
Investor's Business Daily
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
September 12, 2024
An investment in these players today could score a big win down the road.
Via
The Motley Fool
GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech
September 11, 2024
GSK Plc has halted development of its herpes simplex virus vaccine, GSK3943104, after it failed to meet efficacy goals in clinical trials. Moderna and Pfizer's partner BioNTech are still developing HSV...
Via
Benzinga
Is Hims & Hers Health the Next Teladoc?
September 11, 2024
Telemedicine was one of the most in-demand services during the height of the COVID-19 pandemic.
Via
The Motley Fool
Exposures
COVID-19
Wall Street Rallies After Last Week's Sell-Off, Palantir Soars On S&P 500 Inclusion, Airlines Rally: What's Driving Markets Monday?
September 09, 2024
U.S. stocks started the new week with strong gains, as all major indices and sectors in the S&P 500 were in the green by midday in New York. This comes after Wall Street experienced its worst week of...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Moderna Unusual Options Activity
August 27, 2024
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $500 Today
August 23, 2024
Via
Benzinga
Why Is Moderna Stock Trading Higher On Monday?
September 09, 2024
Moderna's Laval, Quebec, facility received a Drug Establishment License from Health Canada, allowing it to produce mRNA vaccines domestically by 2025. The site will manufacture COVID-19, RSV, and flu...
Via
Benzinga
Exposures
COVID-19
Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio?
September 08, 2024
10 worst performing large-cap stocks in August: Super Micro, Dollar General, Snap, PDD Holdings, Intel, Tencent Music, Gold Fields, Charles River, Moderna, Neurocrine Biosciences.
Via
Benzinga
Is It Time to Buy August's Worst-Performing Nasdaq Stocks?
September 07, 2024
These tech stocks got hit hard last month. Should you buy the dip?
Via
The Motley Fool
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
September 06, 2024
Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperform Bavarian Nordic's Jynneos in reducing severe disease in monkeys.
Via
Benzinga
Jim Cramer: Oklo Is Losing Money 'Hand-Over-Fist,' But This Private Equity Stock Is A Buy
September 05, 2024
The "Mad Money" host said Oklo Inc. is a company that is again losing so much money "I can't even look at it."
Via
Benzinga
Is It Time to Buy August's Worst-Performing S&P 500 Stocks?
September 04, 2024
What happened to August's worst-performing stocks? Discover if these underperformers from the famous S&P 500 index are potential buys or value traps.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
UK, Taiwan Approve Moderna's Updated COVID-19 Shot
September 03, 2024
The Medicines and Healthcare Products Regulatory Agency has approved Moderna's updated COVID-19 vaccine targeting the JN.1 variant, available for eligible groups through the NHS autumn program and for...
Via
Benzinga
Exposures
COVID-19
10 Health Care Stocks With Whale Alerts In Today's Session
September 03, 2024
Via
Benzinga
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers
August 31, 2024
The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
August 29, 2024
BioNTech and Moderna are advancing personalized cancer vaccines using mRNA technology. Despite promising early results, these innovative treatments face challenges in cost, scalability, and...
Via
Benzinga
Exposures
COVID-19
This Moderna Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
August 28, 2024
Via
Benzinga
Chinese E-Commerce Giant Drops 35% In 2 Days, But Analysts See 92% Upside Potential
August 27, 2024
PDD Holdings Inc. (NASDAQ: PDD) saw a 29% drop after disappointing Q2 results, but analysts remain bullish with price targets ranging from $84 to $185.
Via
Benzinga
Americans To Access COVID-19 Test Kits For Free As US Government Restarts Free At-Home Program
August 26, 2024
US households can order free COVID-19 tests starting in late September as the government reopens the program ahead of the fall virus season.
Via
Benzinga
Exposures
COVID-19
Snowflake, JD.com And Temu Parent PDD Are Among Top 8 Large Cap Losers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?
August 25, 2024
8 large-cap stocks were the worst performers last week: TBN, GFI, SNOW, NTES, BEN, JD, PDD, MRNA. Are they in your portfolio?
Via
Benzinga
The Stock Market Isn't Rocking This Month But The S&P 500 Is Headed For Its Best August In 3 Years
August 23, 2024
Kellanova and Fortinet are leading the S&P 500's August performance.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Europe Approves Moderna's RSV Vaccine For Adults 60 And Over
August 23, 2024
Moderna secures European Commission approval for its mRNA RSV vaccine, mRESVIA, to protect adults 60+ from RSV-related respiratory disease. The approval follows positive EMA CHMP opinion, based on...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.